SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-303024"
 

Search: onr:"swepub:oai:DiVA.org:uu-303024" > Fracture Rate, Qual...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide : 24-Month Results from the Extended Forsteo Observational Study (ExFOS)

Langdahl, Bente L. (author)
Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Tage Hansens Gade 2, DK-8000 Aarhus, Denmark.
Ljunggren, Östen (author)
Uppsala universitet,Endokrinologi och mineralmetabolism
Benhamou, Claude-Laurent (author)
Orleans Hosp, Orleans, France.
show more...
Marin, Fernando (author)
Eli Lilly & Co, Windlesham, Surrey, England.
Kapetanos, George (author)
Papageorgiou Gen Hosp, Thessaloniki, Greece.
Kocjan, Tomaz (author)
Univ Med Ctr, Ljubljana, Slovenia.
Lespessailles, Eric (author)
Orleans Hosp, Orleans, France.;Univ Orleans, EA 4708 I3MTO, Orleans, France.
Napoli, Nicola (author)
Univ Campus Biomed, Rome, Italy.
Nikolic, Tatjana (author)
Univ Hosp, Zagreb, Croatia.
Petto, Helmut (author)
Eli Lilly & Co, Windlesham, Surrey, England.
Moll, Thomas (author)
Eli Lilly & Co, Windlesham, Surrey, England.
Lindh, Erik (author)
Eli Lilly & Co, Windlesham, Surrey, England.
show less...
Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Tage Hansens Gade 2, DK-8000 Aarhus, Denmark Endokrinologi och mineralmetabolism (creator_code:org_t)
2016-04-30
2016
English.
In: Calcified Tissue International. - : Springer Science and Business Media LLC. - 0171-967X .- 1432-0827. ; 99:3, s. 259-271
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • We describe the pre-planned interim analysis of fracture outcomes, health-related quality of life (HRQoL) and back pain in patients with severe osteoporosis treated with teriparatide for up to 24 months in the Extended Forsteo (Forsteo(A (R)) is a registered trade name of Eli Lilly and Company) Observational Study (ExFOS), a prospective, multinational, observational study. Data on incident clinical fractures, HRQoL (EQ-5D questionnaire) and back pain [100 mm visual analogue scale (VAS)] were collected. The number of patients with fractures was summarised in 6-month intervals and fracture rate over each 6-month period was assessed using logistic regression for repeated measures. Changes from baseline in EQ-5D and back pain VAS were analysed using mixed models for repeated measures. Of 1454 patients in the active treatment cohort, 90.6 % were female and 14.4 % were taking glucocorticoids. During teriparatide treatment (median duration 23.7 months), 103 patients (7.1 %) sustained a total of 122 incident clinical fractures (21 % vertebral, 79 % non-vertebral). A 49 % decrease in the odds of fractures and a 75 % decrease in the odds of clinical vertebral fractures were observed in the > 18- to 24-month period versus the first 6-month period (both p < 0.05). EQ-5D scores and back pain VAS scores were significantly improved from baseline at each post-baseline observation during teriparatide treatment. In conclusion, patients with severe osteoporosis showed a significant reduction in the incident fracture rate during 24 months of teriparatide treatment in routine clinical practice, accompanied by a significant improvement in HRQoL and reduction in back pain. Results should be interpreted in the context of the non-controlled design of this observational study.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)

Keyword

Osteoporosis
Observational study
Teriparatide
Fractures
Quality of life
Back pain

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view